SFG
AUPH icon

Steward Financial Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Steward Financial Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$7K Buy
+1,000
New +$9.78K ﹤0.01% 478
2023
Q2 		– Sell
-1,000
Closed -$10K – 474
2023
Q1 		$10K Buy
+1,000
New +$8.81K ﹤0.01% 188

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Steward Financial Group's AUPH Position: Q3 2023 in Review

Steward Financial Group opened a new position in Aurinia Pharmaceuticals (AUPH) in Q3 2023: 1,000 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #478 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in AUPH as recently as Q1 2023.

Steward Financial Group first reported a position in AUPH in Q1 2023 and has held it in 2 quarters since. The position peaked at $10K in Q1 2023. 198 funds tracked by Wall St. Rank hold AUPH as of Q3 2023.

  • Steward Financial Group held 1,000 shares of Aurinia Pharmaceuticals worth $7K as of Q3 2023.
  • Aurinia Pharmaceuticals was a new Steward Financial Group position in Q3 2023.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #478 holding.
  • Steward Financial Group first reported a position in Aurinia Pharmaceuticals in Q1 2023 and has held it in 2 quarters since.
  • Steward Financial Group's Aurinia Pharmaceuticals position peaked at $10K in Q1 2023.
  • 198 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.